Close Menu

sequencing-based diagnostics

Six percent of patients diagnosed by exome sequencing received more than one molecular diagnosis, which can be important for their clinical management.

The life sciences company can now offer its genetic tests in all 50 states in the US, as well as Canada and several other countries. 

The 95-gene test is for detecting leukemia, myelodysplastic syndromes, and myeloproliferative disorders and can return results in less than one week.

Sequencing technologies were more prevalent than ever at the Association for Molecular Pathology's corporate workshop day.

NEW YORK (GenomeWeb) – Foundation Medicine today said that it has signed a licensing deal with WuXi PharmaTech, enabling that firm to offer Foundation Medicine's genomic profiling technology to companies conducting clinical trials in China.

NEW YORK (GenomeWeb) – Despite a recent study that suggested array-based non-invasive prenatal testing may be an effective alternative to next-generation sequencing-based tests, Illumina appears unconcerned that its customers will switch platforms.

NEW YORK (GenomeWeb) – Med Fusion and GenomOncology have partnered to provide genomic profiles of patient tumors for treatment guidance and clinical trial enrollment, the companies said today.

NEW YORK (GenomeWeb) – Sequenom has purchased intellectual property from Isis Innovations covering noninvasive prenatal testing for nearly $14.6 million, the company said today.

NEW YORK (GenomeWeb) — Illumina has partnered with AstraZeneca, Janssen Biotech, and Sanofi to develop a universal next-generation sequencing-based oncology test system for multi-analyte companion diagnostics, the company said today.

NEW YORK (GenomeWeb) – Myriad Genetics reported after the close of the market Tuesday that its fourth quarter revenues rose 8 percent year over year.

Pages

The Guardian reports that visa costs could prevent scientists and others from coming to the UK.

The Trump Administration is reconsidering its plan to issue an executive order to require federally funded research to be freely available upon publication, Times Higher Education reports.

Nature News says some preprint repositories may close down due to a lack of funds to cover costs.

In Nature this week: framework for analyzing cancer mutational signatures, treatment resistance in small cell lung cancer followed by increased intratumoral heterogeneity, and more.